Hepatitis B Vaccine (Recombinant) Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT02109354Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
NCT00000745A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160